Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)
- Authors
- Jo, JC[Jo, Jae-Cheol]; Lee, HS[Lee, Ho Sup]; Suh, C[Suh, Cheolwon]; Kang, HJ[Kang, Hye Jin]; Kim, WS[Kim, Won Seog]; Eom, H[Eom, HyeonSeok]; Kim, I[Kim, Inho]; Shin, HJ[Shin, Ho-Jin]; Park, Y[Park, Yong]; Lee, WS[Lee, Won Sik]; Do, YR[Do, Young Rok]; Gyeong-Won, L[Gyeong-Won, Lee]; Oh, SY[Oh, Sung Yong]; Lim, SN[Lim, Sung-Nam]; Lee, SY[Lee, Seong Yoon]
- Issue Date
- 13-Nov-2019
- Publisher
- AMER SOC HEMATOLOGY
- Citation
- BLOOD, v.134
- Indexed
- SCIE
SCOPUS
- Journal Title
- BLOOD
- Volume
- 134
- ISSN
- 0006-4971
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.